
TIDEL-II : fi rst-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targets
Yeung, David T, Osborn, Michael P, White, Deborah L, Branford, Susan, Braley, Jodi, Herschtal, Alan, Kornhauser, Michael, Issa, Samar, Hiwase, Devendra K, Hertzberg, Mark, Schwarer, Anthony P, FilshieVolume:
125
Année:
2015
Langue:
english
DOI:
10.1182/blood-2014-07-590315.Presented
Fichier:
PDF, 966 KB
english, 2015